Bio-manufacturing instruments and techniques have become influential in everything from generating high yield pharmaceutical precursors, to biofuel conversion from biomass. Bioprocessing, or the mass production of therapeutic products, includes three production phases: upstream, fermentation, and downstream processing, each providing an opportunity for improvement in efficiency.
In the first two articles of this series we covered the recent industry events within the HPLC market and gave a technical overview of 10 of its sub-technologies. This article will take a sneak peek into our 2018 HPLC Market Analysis and Perspectives report and give some insight into the future of this $5+ billion-dollar […]
In our previous post we highlighted recent advancements within the mass spectrometry (MS) market. Key suppliers in the mass spec industry (i.e Thermo Fisher, Aglient, SCIEX, etc.) showcased their newest technologies at the ASMS Conference held in June and many formed partnerships to improve life science applications of mass spec. Our recently published 2018 Mass […]
The last 6 months have been full of innovation and advancement for the mass spectrometry (MS) industry. As it’s one of the most dynamic branches of analytical instrumentation, even small technological improvements can vastly enhance the efficiency of analysis and spur growth.
Our intention is to inform businesses about the entire market for HPLC, including every associated instrument, consumable, or service.
Sales and marketing managers within our industry are looking at Latin America and wondering if opportunities in the region have been underestimated.
We’re approximately half way through 2018, and our clients continue to innovate and release new products that enhance the level of productivity and efficiency of their scientific customers. Here at BioInformatics Inc. we’re very proud of our ability to deliver Voice of Customer research to our clients’ New Product Development (NPD) initiatives. To stay on […]
LOS ANGELES — Strategic Directions International (SDi), a division of BioInformatics Inc., today announced the release of the SDi Global Assessment Report 2018: The Laboratory Analytical & Life Science Instrumentation Industry. The 800+ page report details updated size, growth and market analyses for over 50 instruments in six major technology categories. In addition the projections, based on […]
March 2, 2020 3:06 pm
February 28, 2019 7:16 pm
September 14, 2018 12:44 pm
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.